Acurx Pharmaceuticals Cash Flow Statement 2019-2024 | ACXP

Fifteen years of historical annual cash flow statements for Acurx Pharmaceuticals (ACXP).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-14.58$-12.09$-12.75$-4.60$-5.93
$0$0$0$0$0
$3.77$3.30$7.59$2.05$0.90
$3.77$3.30$7.59$2.05$0.90
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0.16$0.03$-0.25$0.00$-0.02
$1.14$1.25$0.14$-0.80$1.05
$-9.80$-7.54$-5.01$-3.35$-3.99
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$8.16$3.70$14.80$4.04$4.46
$8.16$3.70$14.80$4.04$4.46
$-1.64$-3.85$9.78$0.69$0.47
$3.77$3.30$6.74$1.27$0.90
$0$0$0$0$0